Barely Significant
← all excerpts

The Prognostic Value of the Prostate Adenocarcinoma With Ductal Feature in Patients With Advanced Prostate Cancer Treated With Abiraterone Acetate.

Prostate · 2025 · PMC12000715 · PMID 40035401

Europe PMCDOI
1
hedged sentence
0.2820
closest p · 5.6× alpha
0.2820
boldest claim

The sentences

showed a trendp = 0.282not close (p > 0.1)
Cox regression analysis revealed that while PAC with ductal feature was not a significant factor in predicting PSA‐PFS and rPFS, it showed a trend toward improved survival outcomes (PSA‐PFS: HR: 0.63; 95% CI: 0.27−1.46; p = 0.282; rPFS: HR: 0.86; 95% CI: 0.39−1.88; p = 0.698) (Table 2 ). 3.3.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.